Literature DB >> 31623897

Effects of preoperative radiotherapy or chemoradiotherapy on postoperative pathological outcome of cervical cancer--from the large database of 46,313 cases of cervical cancer in China.

Weili Li1, Ping Liu1, Weidong Zhao2, Zhaohong Yin1, Zhong Lin3, Xiaonong Bin4, Jinghe Lang5, Chunlin Chen6.   

Abstract

OBJECTIVE: To investigate the effect of preoperative radiotherapy or chemoradiotherapy combined with radical surgery on pathological outcomes in cervical cancer patients.
METHODS: Based on a large Chinese cervical cancer database of clinical diagnosis and treatment (C4 Project), the postoperative pathological outcomes of patients who received preoperative radiotherapy or chemoradiotherapy followed by open surgery (PR group) or surgery alone (SD group) were compared.
RESULTS: Among the strictly selected patients, the incidence of lymph node metastasis in the PR group (n = 574) was higher than that in the SD group (231 VS 9; P < 0.001), while the incidence of vascular space invasion was lower than that in the SD group (72 VS 2041; P < 0.001). The logistic regression analysis showed that preoperative radiotherapy was a protective factor for parametrial involvement, positive surgical margins, deep cervical stromal invasion, and vascular space invasion (P < 0.05). The median number of resected lymph nodes in both groups was 18. After 1:1 case matching, the incidence of deep cervical stromal invasion and vascular space invasion was reduced by preoperative radiotherapy (292 vs 376, P < 0.001; 60 vs 106, P < 0.001). Logistic regression analysis indicated that preoperative radiotherapy was a protective factor for deep cervical stromal invasion and vascular space invasion (P < 0.05). The median numbers of resected lymph nodes in the two groups were 18 and 19, separately.
CONCLUSION: Preoperative radiotherapy can reduce both the incidence of deep cervical stromal invasion and vascular space invasion, but it cannot reduce lymph node positivity, parametrial involvement and positive surgical margins.
Copyright © 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.

Entities:  

Keywords:  Cervical cancer; Pathology; Radiotherapy; Radiotherapy and chemotherapy

Year:  2019        PMID: 31623897     DOI: 10.1016/j.ejso.2019.09.188

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  Uterine corpus invasion in cervical cancer: a multicenter retrospective case-control study.

Authors:  Weili Li; Fangjie He; Ping Liu; Hui Duan; Yan Ni; Shaoguang Wang; Lihong Lin; Zhaohong Yin; Xiaolin Chen; Lu Yin; Lixia Wang; Yueping Liu; Zhonghua Luan; Chunlin Chen
Journal:  Arch Gynecol Obstet       Date:  2021-02-05       Impact factor: 2.344

2.  Comparison between laparoscopic and abdominal radical hysterectomy for low-risk cervical cancer: a multicentre retrospective study.

Authors:  Zhiqiang Li; Chunlin Chen; Ping Liu; Anwei Lu; Hongwei Zhao; Xuemei Zhan; Hui Duan; Pengfei Li; Weidong Zhao; Jilong Yao; Donglin Li; Haixia Jiang; Mubiao Liu; Xiaonong Bin; Jinghe Lang
Journal:  Arch Gynecol Obstet       Date:  2021-08-18       Impact factor: 2.344

3.  Combining nutritional status with TNM stage: a physiological update on gastric cancer staging for improving prognostic accuracy in elderly patients.

Authors:  Kotaro Sugawara; Hiroharu Yamashita; Masayuki Urabe; Yukari Uemura; Yasuhiro Okumura; Koichi Yagi; Susumu Aikou; Yasuyuki Seto
Journal:  Int J Clin Oncol       Date:  2022-10-18       Impact factor: 3.850

4.  The long-term outcomes of clinical responders to neoadjuvant chemotherapy followed by radical surgery in locally advanced cervical cancer.

Authors:  Weili Li; Ping Liu; Fangjie He; Lixin Sun; Hongwei Zhao; Li Wang; Jianxin Guo; Ying Yang; Xiaonong Bin; Jinghe Lang; Chunlin Chen
Journal:  J Cancer Res Clin Oncol       Date:  2022-10-21       Impact factor: 4.322

5.  Neoadjuvant Chemotherapy Followed by Surgery Versus Abdominal Radical Hysterectomy Alone for Oncological Outcomes of Stage IB3 Cervical Cancer-A Propensity Score Matching Analysis.

Authors:  Weili Li; Wenling Zhang; Lixin Sun; Li Wang; Zhumei Cui; Hongwei Zhao; Danbo Wang; Yi Zhang; Jianxin Guo; Ying Yang; Wuliang Wang; Xiaonong Bin; Jinghe Lang; Ping Liu; Chunlin Chen
Journal:  Front Oncol       Date:  2021-09-13       Impact factor: 6.244

6.  Development and validation of a prognostic nomogram for 2018 FIGO stages IB1, IB2, and IIA1 cervical cancer: a large multicenter study.

Authors:  Xiaolin Chen; Hui Duan; Ping Liu; Lihong Lin; Yan Ni; Donglin Li; Encheng Dai; Xuemei Zhan; Pengfei Li; Zhifeng Huo; Xiaonong Bin; Jinghe Lang; Chunlin Chen
Journal:  Ann Transl Med       Date:  2022-01

7.  Discussion on the rationality of FIGO 2018 stage IIIC for cervical cancer with oncological outcomes: a cohort study.

Authors:  Zhiqiang Li; Hui Duan; Jianxin Guo; Ying Yang; Wuliang Wang; Min Hao; Weili Li; Pengfei Li; Xiaonong Bin; Jinghe Lang; Ping Liu; Chunlin Chen
Journal:  Ann Transl Med       Date:  2022-01

8.  Discussion on the Treatment Strategy for Stage ⅡA1 Cervical Cancer (FIGO 2018).

Authors:  Xiaolin Chen; Wentong Liang; Hui Duan; Minling Wu; Xuemei Zhan; Encheng Dai; Qiubo Lv; Qinghuang Xie; Ruilei Liu; Yan Xu; Xiaonong Bin; Jinghe Lang; Ping Liu; Chunlin Chen
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

9.  The Overall Quality of Life and Oncological Outcomes Following Radical Hysterectomy in Cervical Cancer Survivors Results from a Large Long-Term Single-Institution Study.

Authors:  Mihai Stanca; Dan Mihai Căpîlna; Cristian Trâmbițaș; Mihai Emil Căpîlna
Journal:  Cancers (Basel)       Date:  2022-01-09       Impact factor: 6.639

10.  Downregulation of Diacylglycerol kinase zeta (DGKZ) suppresses tumorigenesis and progression of cervical cancer by facilitating cell apoptosis and cell cycle arrest.

Authors:  Keying Liu; Biyun Xue; Guiqin Bai; Wentao Zhang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.